Concepts (59)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sexually Transmitted Diseases | 4 | 2022 | 96 | 1.300 |
Why?
|
| Condylomata Acuminata | 2 | 2019 | 9 | 0.660 |
Why?
|
| Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | 1 | 2016 | 7 | 0.510 |
Why?
|
| Anus Diseases | 1 | 2016 | 8 | 0.500 |
Why?
|
| Papillomavirus Infections | 2 | 2019 | 129 | 0.470 |
Why?
|
| Sexual Behavior | 1 | 2017 | 194 | 0.470 |
Why?
|
| Respiratory Tract Infections | 1 | 2016 | 89 | 0.470 |
Why?
|
| Adolescent Behavior | 1 | 2017 | 193 | 0.470 |
Why?
|
| Education, Medical, Continuing | 1 | 2016 | 96 | 0.470 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 762 | 0.340 |
Why?
|
| Vaccination | 2 | 2022 | 364 | 0.260 |
Why?
|
| HIV Infections | 2 | 2022 | 970 | 0.200 |
Why?
|
| Pharmacies | 1 | 2022 | 36 | 0.190 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2022 | 44 | 0.180 |
Why?
|
| United States | 4 | 2022 | 7855 | 0.160 |
Why?
|
| Adolescent | 2 | 2022 | 6248 | 0.150 |
Why?
|
| Female | 6 | 2022 | 32912 | 0.140 |
Why?
|
| Coitus | 1 | 2017 | 15 | 0.130 |
Why?
|
| Unsafe Sex | 1 | 2017 | 27 | 0.130 |
Why?
|
| Pandemics | 1 | 2022 | 673 | 0.130 |
Why?
|
| RNA, Messenger | 1 | 2022 | 1537 | 0.120 |
Why?
|
| Guidelines as Topic | 1 | 2017 | 157 | 0.120 |
Why?
|
| Risk-Taking | 1 | 2017 | 162 | 0.120 |
Why?
|
| Humans | 8 | 2022 | 63512 | 0.110 |
Why?
|
| Hygiene | 1 | 2013 | 13 | 0.100 |
Why?
|
| Hand Disinfection | 1 | 2013 | 18 | 0.100 |
Why?
|
| Male | 4 | 2019 | 29927 | 0.100 |
Why?
|
| Child | 1 | 2022 | 4528 | 0.090 |
Why?
|
| Incidence | 1 | 2016 | 1380 | 0.090 |
Why?
|
| Age Factors | 1 | 2016 | 1561 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 724 | 0.090 |
Why?
|
| Guideline Adherence | 1 | 2013 | 305 | 0.080 |
Why?
|
| Physicians | 1 | 2016 | 471 | 0.080 |
Why?
|
| Surveys and Questionnaires | 1 | 2016 | 2681 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2016 | 5699 | 0.060 |
Why?
|
| Adult | 2 | 2019 | 16837 | 0.050 |
Why?
|
| Education, Pharmacy, Continuing | 1 | 2022 | 3 | 0.050 |
Why?
|
| Middle Aged | 2 | 2019 | 17641 | 0.050 |
Why?
|
| Sexual Partners | 1 | 2022 | 76 | 0.050 |
Why?
|
| Prisons | 1 | 2022 | 111 | 0.040 |
Why?
|
| Pharmacists | 1 | 2022 | 127 | 0.040 |
Why?
|
| Lewis X Antigen | 1 | 2019 | 6 | 0.040 |
Why?
|
| HIV Core Protein p24 | 1 | 2019 | 17 | 0.040 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2019 | 20 | 0.040 |
Why?
|
| Receptors, CXCR4 | 1 | 2019 | 36 | 0.040 |
Why?
|
| Granulocytes | 1 | 2019 | 71 | 0.040 |
Why?
|
| Papillomaviridae | 1 | 2019 | 59 | 0.040 |
Why?
|
| Prevalence | 1 | 2022 | 1380 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2019 | 347 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2019 | 622 | 0.030 |
Why?
|
| Mass Screening | 1 | 2022 | 691 | 0.030 |
Why?
|
| Skin | 1 | 2019 | 374 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2019 | 525 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 641 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 677 | 0.030 |
Why?
|
| HIV-1 | 1 | 2019 | 721 | 0.030 |
Why?
|
| Macrophages | 1 | 2019 | 1039 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 4700 | 0.020 |
Why?
|
| Aged | 1 | 2019 | 14469 | 0.010 |
Why?
|